Emergent Biosolutions EBS All other revenue — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's all other revenue — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's all other revenue — total revenues?
- Emergent Biosolutions (EBS) reported all other revenue — total revenues of $11.4M in Q1 2026.
- How has Emergent Biosolutions's all other revenue — total revenues changed year-over-year?
- Emergent Biosolutions's all other revenue — total revenues decreased by 43.8% year-over-year, from $20.3M to $11.4M.
- What is the long-term trend for Emergent Biosolutions's all other revenue — total revenues?
- Over 2 years (2023 to 2025), Emergent Biosolutions's all other revenue — total revenues has grown at a -24.3% compound annual growth rate (CAGR), from $104.8M to $60.1M.
- What does all other revenue — total revenues mean?
- This metric represents the aggregate revenue generated from business activities or product lines that do not fall under the company's primary reporting segments. It captures secondary revenue streams, such as ancillary services, non-core product sales, or miscellaneous contract work, providing insight into the diversification of the company's income base. Monitoring this figure helps investors understand the contribution of peripheral operations to the overall financial performance of the organization.